| ADR Ontology |
| ADR Term |
Angiocentric lymphoma |
| ADR ID |
BADD_A00230 |
| ADR Hierarchy |
|
| Description |
A condition that is characterized by inflammation, ulceration, and perforation of the nose and the PALATE with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of EXTRANODAL NK-T-CELL LYMPHOMA and GRANULOMATOSIS WITH POLYANGIITIS. | A condition that is characterized by multiple sites of lymphoid infiltration, often with an aggressive, necrotizing lesion of the upper airway. The term was used as a synonym for lethal midline granuloma. [MeSH] |
| MedDRA Code |
10002411 |
| MeSH ID |
D006103; D008230
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Angiocentric immunoproliferative lesion grade 2 | Angiocentric immunoproliferative lesion grade 3 | Angiocentric lymphoma | Angiocentric lymphoma NOS | Diffuse large cell lymphoma (Angiocentric lymphoma) (Working Formulation) | Diffuse mixed small and large cell lymphoma (Angiocentric lymphoma) (Working Formulation) | Diffuse small cleaved cell lymphoma (Angiocentric lymphoma) (Working Formulation) | Idiopathic midline granuloma | Large cell immunoblastic lymphoma (Angiocentric lymphoma) (Working Formulation) | Lethal midline granuloma | Lymphomatoid granulomatosis | Midline malignant reticulosis | Nasal T-cell lymphoma | Polymorphic reticulosis | Extranodal NK/T-cell lymphoma, nasal type | Extranodal NK/T-cell lymphoma | Granuloma, Lethal Midline | Granulomas, Lethal Midline | Lethal Midline Granulomas | Midline Granuloma, Lethal | Midline Granulomas, Lethal | Lethal Midline Granuloma | Granuloma Gangraenescens | Polymorphic Reticulosis | Polymorphic Reticuloses | Reticuloses, Polymorphic | Reticulosis, Polymorphic |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
